Human bone marrow |
Reduced apoptosis and increased proliferation of renal tubule epithelial cells |
(166) |
Rat bone marrow |
Reduced inflammatory cytokines (IL1β; TNFα) |
(182) |
Human umbilical cord |
Antioxidation through activation of Nrf2/antioxidant response elements (ARE) and decreased expression of NOX2 |
(183, 184) |
Human umbilical cord |
Decreased renal fibrosis (downregulation of CX3CL1, decrease of CD68+macrophages); increased angiogenesis (increased expression of renal VEGF) |
(185–187) |
Human umbilical cord |
Tubular cell dedifferentiation and growth (increased ERK1/2 and HGE expression) |
(188) |
Human umbilical cord |
Inhibition of mitochondrial fission (miR-30) and reduced apoptosis |
(176) |
Mouse kidney resident |
Increased proliferation and reduced apoptosis; increased angiogenesis |
(189) |
Mouse kidney resident (glomeruli) |
Increased proliferation of renal tubule epithelial cells |
(190) |
Rat adipose tissue |
Inhibition of oxidative stress, apoptosis, renal fibrosis |
(191) |
Human umbilical cord |
Increased proliferation and fibrosis (releasing from G2/M cell cycle arrest) |
(192) |
Human bone marrow |
Inhibition of apoptosis (downregulation of Sema3A expression and activation of AKT/ERK pathways through miR-199a-3p); inhibition of NK |
(193) |
Human umbilical cord |
Inhibition of apoptosis, increased proliferation of renal tubule epithelial cells; reduced CD68+macrophages infiltration; reduced fibrosis (decreased expression of aSMA and TGFβ; increased expression of HGF) |
(194) |
Human BM |
Suppression of endoplasmic reticulum stress (miR-199a-5p) |
(177) |